Huarong Chemical Co., Ltd. (SHE:301256)
China · Delayed Price · Currency is CNY 10.00
-0.31 (-3.01%)
At close: Sep 10, 2026
Huarong Chemical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 1,649 | 1,666 | 1,197 | 1,051 | 1,132 | 641.21 |
Other Revenue | 22.76 | 20.45 | 9.84 | 8.07 | 2.96 | 3.17 |
| 1,672 | 1,687 | 1,206 | 1,059 | 1,135 | 644.38 | |
Revenue Growth | 14.76% | 39.80% | 13.89% | -6.67% | 76.14% | -31.89% |
Cost of Revenue | 1,535 | 1,539 | 1,022 | 874.55 | 950.02 | 484.66 |
Gross Profit | 137.69 | 147.99 | 184.35 | 184.77 | 184.99 | 159.73 |
Selling, General & Admin | 51.86 | 51.68 | 69.25 | 69.14 | 57.39 | 42.86 |
Research & Development | 19.03 | 33.9 | 46.37 | 51.71 | 8.68 | 10.1 |
Other Operating Expenses | 10.99 | 8.29 | 8.06 | 8.84 | 9.01 | 5.09 |
Operating Expenses | 82.77 | 94.09 | 124.12 | 131.29 | 75.87 | 58.87 |
Operating Income | 54.92 | 53.89 | 60.23 | 53.49 | 109.12 | 100.86 |
Interest Expense | -2.98 | -4.52 | -9.45 | -11.44 | -4.82 | -1.21 |
Interest & Investment Income | 22.16 | 32.17 | 49.8 | 104.06 | 29.28 | 6.02 |
Currency Exchange Gain (Loss) | -0.18 | -0.09 | 0.35 | 10.87 | 3.39 | -0.16 |
Other Non Operating Income (Expenses) | -1.31 | -0.96 | -0.63 | -0.56 | -0.29 | -0.09 |
EBT Excluding Unusual Items | 72.61 | 80.48 | 100.31 | 156.42 | 136.68 | 105.43 |
Gain (Loss) on Sale of Investments | 2.16 | 0.11 | 0.05 | 0.79 | 0.08 | - |
Gain (Loss) on Sale of Assets | 0.96 | 0.87 | 2.07 | -0.83 | - | 7.72 |
Asset Writedown | - | - | - | - | -0.03 | - |
Other Unusual Items | 5.46 | 3.46 | 12.45 | 3.4 | 5.56 | 5.46 |
Pretax Income | 81.2 | 84.92 | 114.87 | 159.79 | 142.29 | 118.6 |
Income Tax Expense | 11.32 | 13.13 | 14.37 | 21.11 | 20.14 | 16.72 |
Net Income | 69.87 | 71.79 | 100.5 | 138.67 | 122.15 | 101.88 |
Net Income to Common | 69.87 | 71.79 | 100.5 | 138.67 | 122.15 | 101.88 |
Net Income Growth | -21.81% | -28.57% | -27.53% | 13.53% | 19.90% | -1.37% |
Shares Outstanding (Basic) | 502 | 479 | 479 | 478 | 452 | 364 |
Shares Outstanding (Diluted) | 502 | 479 | 479 | 478 | 452 | 364 |
Shares Change | 7.01% | 0.01% | 0.08% | 5.70% | 24.34% | 2.15% |
EPS (Basic) | 0.14 | 0.15 | 0.21 | 0.29 | 0.27 | 0.28 |
EPS (Diluted) | 0.14 | 0.15 | 0.21 | 0.29 | 0.27 | 0.28 |
EPS Growth | -26.93% | -28.57% | -27.59% | 7.41% | -3.57% | -3.45% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Free Cash Flow | -49.63 | -8.26 | -55.78 | -10.33 | 80.53 | -38.14 |
Free Cash Flow Per Share | -0.10 | -0.02 | -0.12 | -0.02 | 0.18 | -0.10 |
Dividend Per Share | 0.130 | 0.140 | 0.170 | 0.200 | 0.080 | 0.050 |
Dividend Growth | -18.75% | -17.65% | -15.00% | 150.00% | 60.00% | - |
Gross Margin | 8.23% | 8.77% | 15.28% | 17.44% | 16.30% | 24.79% |
Operating Margin | 3.28% | 3.19% | 4.99% | 5.05% | 9.61% | 15.65% |
Profit Margin | 4.18% | 4.26% | 8.33% | 13.09% | 10.76% | 15.81% |
Free Cash Flow Margin | -2.97% | -0.49% | -4.62% | -0.97% | 7.09% | -5.92% |
EBITDA | 88.3 | 85.57 | 93.49 | 79.25 | 127.71 | 113.14 |
EBITDA Margin | 5.28% | 5.07% | 7.75% | 7.48% | 11.25% | 17.56% |
D&A For EBITDA | 33.39 | 31.68 | 33.27 | 25.77 | 18.59 | 12.28 |
EBIT | 54.92 | 53.89 | 60.23 | 53.49 | 109.12 | 100.86 |
EBIT Margin | 3.28% | 3.19% | 4.99% | 5.05% | 9.61% | 15.65% |
Effective Tax Rate | 13.94% | 15.46% | 12.51% | 13.21% | 14.15% | 14.10% |
Revenue as Reported | 1,672 | 1,687 | 1,206 | 1,059 | 1,135 | - |
Advertising Expenses | - | 0.01 | 0.04 | 0.77 | 0 | - |